Page last updated: 2024-10-29

iohexol and Cystadenocarcinoma

iohexol has been researched along with Cystadenocarcinoma in 1 studies

Iohexol: An effective non-ionic, water-soluble contrast agent which is used in myelography, arthrography, nephroangiography, arteriography, and other radiographic procedures. Its low systemic toxicity is the combined result of low chemotoxicity and low osmolality.
iohexol : A benzenedicarboxamide compound having N-(2,3-dihydroxypropyl)carbamoyl groups at the 1- and 3-positions, iodo substituents at the 2-, 4- and 6-positions and an N-(2,3-dihydroxypropyl)acetamido group at the 5-position.

Cystadenocarcinoma: A malignant neoplasm derived from glandular epithelium, in which cystic accumulations of retained secretions are formed. The neoplastic cells manifest varying degrees of anaplasia and invasiveness, and local extension and metastases occur. Cystadenocarcinomas develop frequently in the ovaries, where pseudomucinous and serous types are recognized. (Stedman, 25th ed)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kim, JY1
Kim, SH1
Eun, HW1
Lee, MW1
Lee, JY1
Han, JK1
Choi, BI1

Other Studies

1 other study available for iohexol and Cystadenocarcinoma

ArticleYear
Differentiation between biliary cystic neoplasms and simple cysts of the liver: accuracy of CT.
    AJR. American journal of roentgenology, 2010, Volume: 195, Issue:5

    Topics: Adult; Aged; Biliary Tract Neoplasms; Chi-Square Distribution; Contrast Media; Cystadenocarcinoma; C

2010